Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?

Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?

Objective: The number of markers showing the severity of the disease and the number of drugs that can be used in the treatment is very low in vasooclusive crises seen in patients with sickle cell anemia. This study aims to evaluate the levels and changes of serum galectin-3 levels, which are known t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical Science and Discovery 2022-02, Vol.9 (2)
Hauptverfasser: Koyuncu, Mahmut Bakir, Basir, Hakan, Karadurmus, Berkan, Unal, Selma, Tombak, Anil, Tiftik, Eyup Naci
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page
container_title Medical Science and Discovery
container_volume 9
creator Koyuncu, Mahmut Bakir
Basir, Hakan
Karadurmus, Berkan
Unal, Selma
Tombak, Anil
Tiftik, Eyup Naci
description Objective: The number of markers showing the severity of the disease and the number of drugs that can be used in the treatment is very low in vasooclusive crises seen in patients with sickle cell anemia. This study aims to evaluate the levels and changes of serum galectin-3 levels, which are known to have many roles in the body, during a painful crisis. Material and Methods: In addition to the 0th and 48th hour galectin-3 levels in patients hospitalized for a painful crisis, galectin-3 measurements were also performed in stable patients with sickle cell anemia and healthy individuals. Results: Galectin-3 levels were statistically significantly different in patient groups (p=0.001). It was observed that galectin-3 levels at the 48th hour were markedly higher than at the 0th hour in patients with painful crises. It was found that galectin-3 levels at both 0th and 48th hours were correlated with the duration of hospitalization due to painful crisis and the period of intravenous opioid use. Conclusion: Galectin-3 levels, which are elevated during the painful crisis in patients with sickle cell anemia, are associated with the severity of the painful crisis
doi_str_mv 10.36472/msd.v9i2.675
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_36472_msd_v9i2_675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_36472_msd_v9i2_675</sourcerecordid><originalsourceid>FETCH-LOGICAL-c825-471bfe58a0126146b6f8a0a896ae72de1b0f4d72b78234c5ecd1c7a7600ca9213</originalsourceid><addsrcrecordid>eNpN0EtrwzAQBGBRWmhIc-x9_4BTSZYl-1RK6AsCveRuZHndLFXs4FVc8u_rPg49zcDAHD4hbpVc59Y4fXfgdj1VpNfWFRdioZUpM1vm-vJfvxYrZmqksVbLqioWIm58D-8-YkjUZzk0CCfGFtIAxxFbCgnSHoFxwpHSGYYOJs_DEEI8MU0IYSQmBurh6BNhnxg-Ke2BKXzEecYYwfceD-Tvb8RV5yPj6i-XYvf0uNu8ZNu359fNwzYLpS4y41TTYVF6qbRVxja2m7svK-vR6RZVIzvTOt24UucmFBhaFZx3VsrgK63ypch-b8M4MI_Y1ceRDn4810rWP1j1jFV_Y9UzVv4F2CRfXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Koyuncu, Mahmut Bakir ; Basir, Hakan ; Karadurmus, Berkan ; Unal, Selma ; Tombak, Anil ; Tiftik, Eyup Naci</creator><creatorcontrib>Koyuncu, Mahmut Bakir ; Basir, Hakan ; Karadurmus, Berkan ; Unal, Selma ; Tombak, Anil ; Tiftik, Eyup Naci</creatorcontrib><description>Objective: The number of markers showing the severity of the disease and the number of drugs that can be used in the treatment is very low in vasooclusive crises seen in patients with sickle cell anemia. This study aims to evaluate the levels and changes of serum galectin-3 levels, which are known to have many roles in the body, during a painful crisis. Material and Methods: In addition to the 0th and 48th hour galectin-3 levels in patients hospitalized for a painful crisis, galectin-3 measurements were also performed in stable patients with sickle cell anemia and healthy individuals. Results: Galectin-3 levels were statistically significantly different in patient groups (p=0.001). It was observed that galectin-3 levels at the 48th hour were markedly higher than at the 0th hour in patients with painful crises. It was found that galectin-3 levels at both 0th and 48th hours were correlated with the duration of hospitalization due to painful crisis and the period of intravenous opioid use. Conclusion: Galectin-3 levels, which are elevated during the painful crisis in patients with sickle cell anemia, are associated with the severity of the painful crisis</description><identifier>ISSN: 2148-6832</identifier><identifier>EISSN: 2148-6832</identifier><identifier>DOI: 10.36472/msd.v9i2.675</identifier><language>eng</language><ispartof>Medical Science and Discovery, 2022-02, Vol.9 (2)</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c825-471bfe58a0126146b6f8a0a896ae72de1b0f4d72b78234c5ecd1c7a7600ca9213</citedby><cites>FETCH-LOGICAL-c825-471bfe58a0126146b6f8a0a896ae72de1b0f4d72b78234c5ecd1c7a7600ca9213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Koyuncu, Mahmut Bakir</creatorcontrib><creatorcontrib>Basir, Hakan</creatorcontrib><creatorcontrib>Karadurmus, Berkan</creatorcontrib><creatorcontrib>Unal, Selma</creatorcontrib><creatorcontrib>Tombak, Anil</creatorcontrib><creatorcontrib>Tiftik, Eyup Naci</creatorcontrib><title>Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?</title><title>Medical Science and Discovery</title><description>Objective: The number of markers showing the severity of the disease and the number of drugs that can be used in the treatment is very low in vasooclusive crises seen in patients with sickle cell anemia. This study aims to evaluate the levels and changes of serum galectin-3 levels, which are known to have many roles in the body, during a painful crisis. Material and Methods: In addition to the 0th and 48th hour galectin-3 levels in patients hospitalized for a painful crisis, galectin-3 measurements were also performed in stable patients with sickle cell anemia and healthy individuals. Results: Galectin-3 levels were statistically significantly different in patient groups (p=0.001). It was observed that galectin-3 levels at the 48th hour were markedly higher than at the 0th hour in patients with painful crises. It was found that galectin-3 levels at both 0th and 48th hours were correlated with the duration of hospitalization due to painful crisis and the period of intravenous opioid use. Conclusion: Galectin-3 levels, which are elevated during the painful crisis in patients with sickle cell anemia, are associated with the severity of the painful crisis</description><issn>2148-6832</issn><issn>2148-6832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpN0EtrwzAQBGBRWmhIc-x9_4BTSZYl-1RK6AsCveRuZHndLFXs4FVc8u_rPg49zcDAHD4hbpVc59Y4fXfgdj1VpNfWFRdioZUpM1vm-vJfvxYrZmqksVbLqioWIm58D-8-YkjUZzk0CCfGFtIAxxFbCgnSHoFxwpHSGYYOJs_DEEI8MU0IYSQmBurh6BNhnxg-Ke2BKXzEecYYwfceD-Tvb8RV5yPj6i-XYvf0uNu8ZNu359fNwzYLpS4y41TTYVF6qbRVxja2m7svK-vR6RZVIzvTOt24UucmFBhaFZx3VsrgK63ypch-b8M4MI_Y1ceRDn4810rWP1j1jFV_Y9UzVv4F2CRfXg</recordid><startdate>20220218</startdate><enddate>20220218</enddate><creator>Koyuncu, Mahmut Bakir</creator><creator>Basir, Hakan</creator><creator>Karadurmus, Berkan</creator><creator>Unal, Selma</creator><creator>Tombak, Anil</creator><creator>Tiftik, Eyup Naci</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220218</creationdate><title>Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?</title><author>Koyuncu, Mahmut Bakir ; Basir, Hakan ; Karadurmus, Berkan ; Unal, Selma ; Tombak, Anil ; Tiftik, Eyup Naci</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c825-471bfe58a0126146b6f8a0a896ae72de1b0f4d72b78234c5ecd1c7a7600ca9213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Koyuncu, Mahmut Bakir</creatorcontrib><creatorcontrib>Basir, Hakan</creatorcontrib><creatorcontrib>Karadurmus, Berkan</creatorcontrib><creatorcontrib>Unal, Selma</creatorcontrib><creatorcontrib>Tombak, Anil</creatorcontrib><creatorcontrib>Tiftik, Eyup Naci</creatorcontrib><collection>CrossRef</collection><jtitle>Medical Science and Discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koyuncu, Mahmut Bakir</au><au>Basir, Hakan</au><au>Karadurmus, Berkan</au><au>Unal, Selma</au><au>Tombak, Anil</au><au>Tiftik, Eyup Naci</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?</atitle><jtitle>Medical Science and Discovery</jtitle><date>2022-02-18</date><risdate>2022</risdate><volume>9</volume><issue>2</issue><issn>2148-6832</issn><eissn>2148-6832</eissn><abstract>Objective: The number of markers showing the severity of the disease and the number of drugs that can be used in the treatment is very low in vasooclusive crises seen in patients with sickle cell anemia. This study aims to evaluate the levels and changes of serum galectin-3 levels, which are known to have many roles in the body, during a painful crisis. Material and Methods: In addition to the 0th and 48th hour galectin-3 levels in patients hospitalized for a painful crisis, galectin-3 measurements were also performed in stable patients with sickle cell anemia and healthy individuals. Results: Galectin-3 levels were statistically significantly different in patient groups (p=0.001). It was observed that galectin-3 levels at the 48th hour were markedly higher than at the 0th hour in patients with painful crises. It was found that galectin-3 levels at both 0th and 48th hours were correlated with the duration of hospitalization due to painful crisis and the period of intravenous opioid use. Conclusion: Galectin-3 levels, which are elevated during the painful crisis in patients with sickle cell anemia, are associated with the severity of the painful crisis</abstract><doi>10.36472/msd.v9i2.675</doi></addata></record>
fulltext fulltext
identifier ISSN: 2148-6832
ispartof Medical Science and Discovery, 2022-02, Vol.9 (2)
issn 2148-6832
2148-6832
language eng
recordid cdi_crossref_primary_10_36472_msd_v9i2_675
source EZB-FREE-00999 freely available EZB journals
title Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T00%3A25%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20galectin-3%20be%20used%20to%20predict%20the%20severity%20of%20vasoocclusive%20crisis%20in%20patients%20with%20sickle%20cell%20anaemia?&rft.jtitle=Medical%20Science%20and%20Discovery&rft.au=Koyuncu,%20Mahmut%20Bakir&rft.date=2022-02-18&rft.volume=9&rft.issue=2&rft.issn=2148-6832&rft.eissn=2148-6832&rft_id=info:doi/10.36472/msd.v9i2.675&rft_dat=%3Ccrossref%3E10_36472_msd_v9i2_675%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true